Rxreliance

Peptide. Histone H3, 1-21 K4Me2 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3, 1-16 K4Me3 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Histone H3, 1-18 K4Me2/K9/K14ac Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 40, Arctic Mutant Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 42 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 42, Dutch Mutant Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 42, Iowa Mutant Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 42, Flemish Mutant Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 25-35 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 25-35 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 25-35 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 3-11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 3-11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid pyrE 3-11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid pyrE 3-40 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid pyrE 11-40 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 3-40 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid pyrE 3-42 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid pyrE 11-42 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 3-42 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Beta Amyloid 11-42 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. T-Cell Assay Panel Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. T-Cell Assay Panel Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 36 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 36 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 17 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 17 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, [13C/15N-Pro3, 12] Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, [13C/15N-Pro3, 12] Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 100 uL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dSer6, [13C/15N-Pro3, 12] Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dSer6, [13C/15N-Pro3, 12] Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 100 uL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, [13C/15N-Pro3, 12] Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, dLeu5, [13C/15N-Pro3, 12] Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 100 uL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 N-a-MCA, C-a-DAP(Dnp) Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 N-a-MCA, C-a-DAP(Dnp) Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 N-a-MCA Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 12 N-a-MCA Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. N-a-palmitoyl-apelin 13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. N-a-palmitoyl-apelin 13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. N-a-lauroyl-apelin 13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. N-a-lauroyl-apelin 13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. N-a-myristolyl-apelin 13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. N-a-myristolyl-apelin 13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. N-a-stearoyl-apelin 13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. N-a-stearoyl-apelin 13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Glu2 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Glu2 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys7 Peptide , Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asn11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asn11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Cys11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Cys11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Phe11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Phe11 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Ser10 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Ser10 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, His8 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, His8 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Tyr7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Tyr7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Glu4 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Glu4 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Phe7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Phe7 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Phe5 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Phe5 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Cys6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Cys6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Val6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Val6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Asp6 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Tyr6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Tyr6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Thr6 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Thr6 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Val5 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Val5 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Pro7 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Pro7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Arg7 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Arg7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys7, lle12 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Lys7, lle12 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5, Lys7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, lle5, Lys7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 His1, Lys7 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 His1, Lys7 Control Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 5.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.

Peptide. Apelin 13 pyr1, Leu13 Peptide, Concentration: 1.0 mg/mL by dry weight, Reconstitution Volume: 1.0 mL, Control peptide should be used at 1.0 ug per 1.0 ul of antiserum in per assay, Specific conditions for reactivity should be optimized by the end user.